Increased biological response to 1,25(OH)2D3 in genetic hypercalciuric stone-forming rats

American Journal of Physiology - Renal Physiology

Volumn 304, Issue 6, 2013, Pages

  Frick, Kevin K ^a   Asplin, John R ^b   Favus, Murray J ^c   Culbertson, Christopher ^a   Krieger, Nancy S ^a   Bushinsky, David A ^a  

^a UNIVERSITY OF ROCHESTER SCHOOL OF MEDICINE AND DENTISTRY   (United States)

^b LithoLink Corporation   (United States)

^c UNIVERSITY OF CHICAGO   (United States)

Author keywords

Calcium; Kidney stones; Reabsorption; Vitamin D

Indexed keywords

CALBINDIN; CALCITRIOL; CALCIUM; CLAUDIN 14; CLAUDIN 16; CLAUDIN 19; POTASSIUM CHANNEL; RNA; UNCLASSIFIED DRUG; VANILLOID RECEPTOR 5; VITAMIN D RECEPTOR; BIOLOGICAL MARKER; CALCIUM OXALATE; CALCIUM PHOSPHATE; DICALCIUM PHOSPHATE ANHYDROUS;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; FEEDING; GENETIC POLYMORPHISM; HYPERCALCEMIA; HYPERCALCIURIA; NEPHROLITHIASIS; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; STONE FORMATION; ANIMAL; DISEASE MODEL; KIDNEY; MALE; METABOLISM; SPRAGUE DAWLEY RAT; URINE;

ANIMALS; BIOLOGICAL MARKERS; CALCITRIOL; CALCIUM; CALCIUM OXALATE; CALCIUM PHOSPHATES; DISEASE MODELS, ANIMAL; HYPERCALCEMIA; HYPERCALCIURIA; KIDNEY; KIDNEY CALCULI; MALE; RATS; RATS, SPRAGUE-DAWLEY;

MLCS; MLOWN;

EID: 84878052539     PISSN: 1931857X     EISSN: 15221466     Source Type: Journal    
DOI: 10.1152/ajprenal.00645.2012     Document Type: Article

References (99)

1. Adams ND, Gray RW, Lemann JJ. Effects of calcitriol administration on calcium metabolism in healthy men. Kidney Int 21: 90-97, 1982.
2. Alexander RT, Woudenberg-Vrenken TE, Buurman J, Dijkman H, van der Eerden BC, van Leeuwen JP, Bindels RJ, Hoenderop JG. Klotho prevents renal calcium loss. J Am Soc Nephrol 20: 2371-2379, 2009.
3. Asplin JR, Bushinsky DA, Singharetnam W, Riordon D, Parks JH, Coe FL. Relationship between supersaturation and crystal inhibition in hypercalciuric rats. Kidney Int 51: 640-645, 1997.
4. Asplin JR, Donahue SE, Lindeman C, Michalenka A, Strutz KL, Bushinsky DA. Thiosulfate reduces calcium phosphate nephrolithiasis. J Am Soc Nephrol 20: 1246-1253, 2009.
5. Bai S, Wang H, Shen J, Zhou R, Bushinsky DA, Favus MJ. Elevated vitamin D receptor levels in genetic hypercalciuric stone-forming rats are associated with downregulation of Snail. J Bone Miner Res 25: 830-840, 2010.
6. Bataille P, Bouillion R, Fournier A, Renaud H, Gueris J, Idrissi A. Increased plasma concentrations of total and free 1,25(OH)2D3 in calcium stone formers with idiopathic hypercalciuria. Contrib Nephrol 58: 137-142, 1987.
7. Beck L, Silve C. Molecular aspects of renal tubular handling and regulation of inorganic sulfate. Kidney Int 59: 835-845, 2001.
8. Benn BS, Ajibade D, Porta A, Dhawan P, Hediger M, Peng JB, Jiang Y, Oh GT, Jeung EB, Lieben L, Bouillon R, Carmeliet G, Christakos S. Active intestinal calcium transport in the absence of transient receptor potential vanilloid type 6 and calbindin-D9k. Endocrinology 149: 3196-3205, 2008.
9. Bergsland KJ, Coe FL, Gillen DL, Worcester EM. A test of the hypothesis that the collecting duct calcium-sensing receptor limits rise of urine calcium molarity in hypercalciuric calcium kidney stone formers. Am J Physiol Renal Physiol 297: F1017-F1023, 2009.
10. 2+-sensing receptor. J Vasc Res 46: 73-82, 2009.
11. Bianco SD, Peng JB, Takanaga H, Suzuki Y, Crescenzi A, Kos CH, Zhuang L, Freeman MR, Gouveia CHA, Wu J, Luo H, Mauro T, Brown EM, Hediger MA. Marked disturbance of calcium homeostasis in mice with targeted disruption of the TRPV6 calcium channel gene. J Bone Miner Res 22: 274-285, 2007.
12. 2+ transport in primary cultures of rabbit kidney CCD: stimulation by 1,25-dihydroxyvitamin D3 and PTH. Am J Physiol Renal Fluid Electrolyte Physiol 261: F799-F807, 1991.
13. Blanchard A, Jeunemaitre X, Coudol P, Dechaux M, Froissart M, May A, Demontis R, Fournier A, Paillard M, Houillier P. Paracellin-1 is critical for magnesium and calcium reabsorption in the human thick ascending limb of Henle. Kidney Int 59: 2206-2215, 2001.
14. Broadus AE, Horst RL, Lang R, Littledike ET, Rasmussen H. The importance of circulating 1,25(OH)2D in the pathogenesis of hypercalci-uria and renal stone formation in primary hyperparathyroidism. N Engl J Med 302: 421-426, 1980.
15. Bushinsky DA. Contribution of intestine, bone, kidney, and dialysis to extracellular fluid calcium content. Clin J Am Soc Nephrol 5: S12-S22, 2010.
16. Bushinsky DA, Asplin JR. Thiazides reduce brushite, but not calcium oxalate, supersaturation and stone formation in genetic hypercalciuric stone-forming rats. J Am Soc Nephrol 16: 417-424, 2005.
17. Bushinsky DA, Asplin JR, Grynpas MD, Evan AP, Parker WR, Alexander KM, Coe FL. Calcium oxalate stone formation in genetic hypercalciuric stone-forming rats. Kidney Int 61: 975-987, 2002.
18. Bushinsky DA, Bashir MA, Riordon DR, Nakagawa Y, Coe FL, Grynpas MD. Increased dietary oxalate does not increase urinary calcium oxalate saturation in hypercalciuric rats. Kidney Int 55: 602-612, 1999.
19. Bushinsky DA, Coe FL, Moe OW. Nephrolithiasis. In: The Kidney, edited by Brenner BM. Philadelphia, PA: W. B. Saunders, 2012, p. 1455-1507.
20. Bushinsky DA, Favus MJ. Mechanism of hypercalciuria in genetic hypercalciuric rats: inherited defect in intestinal calcium transport. J Clin Invest 82: 1585-1591, 1988.
21. Bushinsky DA, Grynpas MD, Asplin JR. Effect of acidosis on urine supersaturation and stone formation in genetic hypercalciuric stone forming rats. Kidney Int 59: 1415-1423, 2001.
22. Bushinsky DA, Grynpas MD, Nilsson EL, Nakagawa Y, Coe FL. Stone formation in genetic hypercalciuric rats. Kidney Int 48: 1705-1713, 1995.
23. Bushinsky DA, Kim M, Sessler NE, Nakagawa Y, Coe FL. Increased urinary saturation and kidney calcium content in genetic hypercalciuric rats. Kidney Int 45: 58-65, 1994.
24. Bushinsky DA, LaPlante K, Asplin JR. Effect of cinacalcet on urine calcium excretion and supersaturation in genetic hypercalciuric stone-forming rats. Kidney Int 69: 1586-1592, 2006.
25. Bushinsky DA, Michalenka AC, Strutz KL, Donahue S, Asplin JR. Effect of bolus and divided feeding on urine ions and supersaturation in genetic hypercalciuric stone-forming rats. Kidney Int 73: 423-429, 2007.
26. Bushinsky DA, Monk RD. Calcium. Lancet 352: 306-311, 1998.
27. Bushinsky DA, Neumann KJ, Asplin J, Krieger NS. Alendronate decreases urine calcium and supersaturation in genetic hypercalciuric rats. Kidney Int 55: 234-243, 1999.
28. Bushinsky DA, Parker WR, Asplin JR. Calcium phosphate supersaturation regulates stone formation in genetic hypercalciuric stone-forming rats. Kidney Int 57: 550-560, 2000.
29. Bushinsky DA, Willett T, Asplin JR, Culbertson C, Che SPY, Grynpas M. Chlorthalidone improves vertebral bone quality in genetic hypercalciuric stone-forming rats. J Bone Miner Res 26: 1904-1912, 2011.
30. Cha SK, Ortega B, Kurosu H, Rosenblatt KP, Kuro-o M, Huang CL. Removal of sialic acid involving Klotho causes cell-surface retention of TRPV5 channel via binding to galectin-1. Proc Natl Acad Sci USA 105: 9805-9810, 2008.
31. Evan AP, Bledsoe SB, Smith SB, Bushinsky DA. Calcium oxalate crystal localization and osteopontin immunostaining in genetic hypercalciuric stone-forming rats. Kidney Int 65: 154-161, 2004.
32. Even L, Weisman Y, Goldray D, Hochberg Z. Selective modulation by vitamin D of renal response to parathyroid hormone: a study in calcitriol-resistant rickets. J Clin Endocrinol Metab 81: 2836-2840, 1996.
33. Favus MJ. Hypercalciuria: Lessons from studies of genetic hypercalciuric rats. J Am Soc Nephrol 5: S54-S58, 1994.
34. Favus MJ, Karnauskas AJ, Parks JH, Coe FL. Peripheral blood monocyte vitamin D receptor levels are elevated in patients with idiopathic hypercalciuria. J Clin Endocrinol Metab 89: 4937-4943, 2004.
35. Fernandes I, Hampson G, Cahours X, Morin P, Coureau C, Couette S, Prie D, Biber J, Murer H, Friedlander G, Silve C. Abnormal sulfate metabolism in vitamin D-deficient rats. J Clin Invest 100: 2196-2203, 1997.
36. Forster RE, Jurutka PW, Hsieh JC, Haussler CA, Lowmiller CL, Kaneko I, Haussler MR, Kerr Whitfield G. Vitamin D receptor controls expression of the anti-aging klotho gene in mouse and human renal cells. Biochem Biophys Res Commun 414: 557-562, 2011.
37. Frick KK, Bushinsky DA. Molecular mechanisms of primary hypercalciuria. J Am Soc Nephrol 14: 1082-1095, 2003.
38. 2+ transport in response to CaSR signalling via a novel microRNA pathway. EMBO J 31: 1999-2012, 2012.
39. Grynpas M, Waldman S, Holmyard D, Bushinsky DA. Genetic hypercalciuric stone-forming rats have a primary decrease in bone mineral density and strength. J Bone Miner Res 24: 1420-1426, 2009.
40. Günzel D, Haisch L, Pfaffenbach S, Krug SM, Milatz S, Amasheh S, Hunziker W, Müller D. Claudin function in the thick ascending limb of Henle's loop. Ann NY Acad Sci 1165: 152-162, 2009.
41. 2+ channel in rabbit kidney and intestine. J Am Soc Nephrol 11: 1171-1178, 2000.
42. 2+ wasting, hyperabsorption, and reduced bone thickness in mice lacking TRPV5. J Clin Invest 112: 1906-1914, 2003.
43. Hoenderop JG, Nilius B, Bindels RJ. Calcium absorption across epithe-lia. Physiol Rev 85: 373-422, 2005.
44. Hofman-Bang J, Martuseviciene G, Santini MA, Olgaard K, Lewin E. Increased parathyroid expression of klotho in uremic rats. Kidney Int 78: 1119-1127, 2010.
45. Hoopes RR Jr, Middleton FA, Sen S, Hueber PA, Reid R, Bushinsky DA, and Scheinman SJ. Isolation and confirmation of a calcium excretion quantitative trait locus on chromosome 1 in genetic hypercalciuric stone-forming congenic rats. J Am Soc Nephrol 17: 1292-1304, 2006.
46. Hoopes RR, Reid R, Sen S, Szpirer C, Dixon P, Pannet A, Thakker RV, Bushinsky DA, Scheinman SJ. Quantitative trait loci for hypercalciuria in a rat model of kidney stone disease. J Am Soc Nephrol 14: 1844-1850, 2003.
47. Hou J, Renigunta A, Gomes AS, Hou M, Paul DL, Waldegger S, Goodenough DA. Claudin-16 and claudin-19 interaction is required for their assembly into tight junctions and for renal reabsorption of magnesium. Proc Natl Acad Sci USA 106: 15350-15355, 2009.
48. Insogna KL, Broadus AE, Dryer BE, Ellison AF, Gertner JM. Elevated production rate of 1,25-dihydroxyvitamin D in patients with absorptive hypercalciuria. J Clin Endocrinol Metab 61: 490-495, 1985.
49. Jang Y, Lee Y, Kim S, Yang Y, Jung J, Oh U. Quantitative analysis of TRP channel genes in mouse organs. Arch Pharm (Weinheim) 35: 1823-1830, 2012.
50. Joshi R. Hypercalcemia due to hypervitaminosis D: report of seven patients. J Trop Pediatr 55: 396-398, 2009.
51. Karnauskas AJ, van Leeuwen JP, van den Bemd GJ, Kathpalia PP, DeLuca HF, Bushinsky DA, Favus MJ. Mechanism and function of high vitamin D receptor levels in genetic hypercalciuric stone-forming rats. J Bone Miner Res 20: 447-454, 2005.
52. Kim M, Sessler NE, Tembe V, Favus MJ, Bushinsky DA. Response of genetic hypercalciuric rats to a low calcium diet. Kidney Int 43: 189-196, 1993.
53. Koul PA, Ahamd SH, Ahmad F, Jan RA, Shah SU, Khan UH. Vitamin D toxicity in adults: a case series from an area with endemic hypovita-minosis d. Oman Med J 26: 201-204, 2011.
54. Krieger NS, Stathopoulos VM, Bushinsky DA. Increased sensitivity to 1,25(OH)2D3 in bone from genetic hypercalciuric rats. Am J Physiol Cell Physiol 271: C130-C135, 1996.
55. Kutuzova GD, Sundersingh F, Vaughan J, Tadi BP, Ansay SE, Christakos S, DeLuca HF. TRPV6 is not required for 1,25-dihydroxyvi-tamin D3-induced intestinal calcium absorption in vivo. Proc Natl Acad Sci USA 105: 19655-19659, 2008.
56. Langnaese K, John R, Schweizer H, Ebmeyer U, Keilhoff G. Selection of reference genes for quantitative real-time PCR in a rat asphyxial cardiac arrest model. BMC Mol Biol 9: 53, 2008.
57. Lau WL, Leaf EM, Hu MC, Takeno MM, Kuro-o M, Moe OW, Giachelli CM. Vitamin D receptor agonists increase klotho and osteo-pontin while decreasing aortic calcification in mice with chronic kidney disease fed a high phosphate diet. Kidney Int, 2012.
58. Lee CT, Chen HC, Lai LW, Yong KC, Lien YHH. Effects of furo-semide on renal calcium handling. Am J Physiol Renal Physiol 293: F1231-F1237, 2007.
59. Lee CT, Chen HC, Ng HY, Lai LW, Lien YHH. Renal adaptation to gentamicin-induced mineral loss. Am J Nephrol 35: 279-286, 2012.
60. Lee CT, Lien YHH, Lai LW, Chen JB, Lin CR, Chen HC. Increased renal calcium and magnesium transporter abundance in streptozotocin-induced diabetes mellitus. Kidney Int 69: 1786-1791, 2006.
61. Lee NPY, Tong MK, Leung PP, Chan VW, Leung S, Tam PC, Chan KW, Lee KF, Yeung WSB, Luk JM. Kidney claudin-19: localization in distal tubules and collecting ducts and dysregulation in polycystic renal disease. FEBS Lett 580: 923-931, 2006.
62. Lemann J Jr, Pleuss JA, Worcester EA, Hornick L, Schrab D, Hoffman RG. Urinary oxalate excretion increases with body size and decreases with increasing dietary calcium intake among healthy adults. Kidney Int 49: 200-208, 1996. [Erratum. Kidney Int 250: 341, 1996.
63. Lemann JR, The relation of sulfur metabolism to acid-base balance and electrolyte excretion: the effects of DL-methionine in normal man. J Clin Invest 38: 2215-2223, 1959.
64. Li J, Ananthapanyasut W, Yu A. Claudins in renal physiology and disease. Pediatr Nephrol 26: 2133-2142, 2011.
65. Li XQ, Tembe V, Horwitz GM, Bushinsky DA, Favus MJ. Increased intestinal vitamin D receptor in genetic hypercalciuric rats: a cause of intestinal calcium hyperabsorption. J Clin Invest 91: 661-667, 1993.
66. Lieben L, Benn BS, Ajibade D, Stockmans I, Moermans K, Hediger MA, Peng JB, Christakos S, Bouillon R, Carmeliet G. Trpv6 mediates intestinal calcium absorption during calcium restriction and contributes to bone homeostasis. Bone 47: 301-308, 2010.
67. 2+ channels TRPV5 and TRPV6. Nephrol Dial Transplant 23: 3397-3402, 2008.
68. Maierhofer WJ, Gray RW, Cheung HS, Lemann J. Bone resorption stimulated by elevated serum 1,25-(OH)2 -vitamin D3 concentrations in healthy men. Kidney Int 24: 555-560, 1983.
69. 2+ transport. Intl J Biochem Cell Biol 43: 1-4, 2011.
70. Moe OW, Bonny O. Genetic hypercalciuria. J Am Soc Nephrol 16: 729-745, 2005.
71. Monico CG, Milliner DS. Genetic determinants of urolithiasis. Nat Rev Nephrol 8: 151-162, 2012.
72. Mossetti G, Rendina D, Viceconti R, Manno G, Guadagno V, Straz-zullo P, Nunziata V. The relationship of 3' vitamin D receptor haplotypes to urinary supersaturation of calcium oxalate salts and to age at onset and familial prevalence of nephrolithiasis. Nephrol Dial Transplant 19: 2259-2265, 2004.
73. Mossetti G, Vuotto P, Redina D, Numis FG, Viceconti R, Giordano F, Cioffi M, Scopacasa F, Nunziata V. Association between vitamin D receptor gene polymorphisms and tubular citrate handling in calcium nephrolithiasis. J Int Med Res 253: 194-200, 2003.
74. 2+ influx and respiratory burst in microglia. Channels 1: 366-376, 2007.
75. 2+ channel TRPV6 in the kidney. J Am Soc Nephrol 14: 2731-2740, 2003.
76. +-dependent HCO3 transporter NBCn1-mediated HCO3 influx in rat medullary thick ascending limb. J Physiol 555: 205-218, 2004.
77. Okamoto N, Aruga S, Tomita K, Takeuchi T, Kitamura T. Chronic acid ingestion promotes renal stone formation in rats treated with vitamin D3. Intl J Urol 14: 60-66, 2007.
78. Onishi T, Shintani S, Wakisaka S, Ooshima T. Relationship of vitamin D with calbindin D9k and D28k expression in ameloblasts. Arch Oral Biol 53: 117-123, 2008.
79. Öoz OK, Hajibeigi A, Howard K, Cummins CL, van Abel M, Bindels RJ, Word RA, Kuro-o M, Pak CY, Zerwekh JE. Aromatase deficiency causes altered expression of molecules critical for calcium reabsorption in the kidneys of female mice. J Bone Miner Res 22: 1893-1902, 2007.
80. Perry GM, Nehrke KW, Bushinsky DA, Reid R, Lewandowski KL, Hueber P, Scheinman SJ. Sex modifies genetic effects on residual variance in urinary calcium excretion in rat (Rattus norvegicus). Genetics 191: 1003-1013, 2012.
81. Quarles LD. Endocrine functions of bone in mineral metabolism regulation. J Clin Invest 118: 3820-3828, 2008.
82. Sands JM, Naruse M, Baum M, Jo I, Hebert SC, Brown EM, Harris HW. Apical extracellular calcium/polyvalent cation-sensing receptor regulates vasopressin-elicited water permeability in rat kidney inner medullary collecting duct. J Clin Invest 99: 1399-1405, 1997.
83. Shen FH, Baylink DJ, Nielsen RL. Increased serum 1,25-dihydroxy cholecalciferol (1,25 diOHD3) in patients with idiopathic hypercalciuria (IH). Clin Res 23: 423A, 1975.
84. Spector DA, Yang Q, Klopouh L, Deng J, Weinman EJ, Steplock DA, Biswas R, Brazie MF, Liu J, Wade JB. The ROMK potassium channel is present in mammalian urinary tract epithelia and muscle. Am J Physiol Renal Physiol 295: F1658-F1665, 2008.
85. Stechman MJ, Loh NY, Thakker RV. Genetics of hypercalciuric nephrolithiasis: renal stone disease. Ann NY Acad Sci 1116: 461-484, 2007.
86. Suzuki M, Ishibashi K, Ooki G, Tsuruoka S, Imai M. Electrophysiologic characteristics of the Ca-permeable channels, ECaC and CaT, in the kidney. Biochem Biophys Res Commun 274: 344-349, 2000.
87. Suzuki Y, Pasch A, Bonny O, Mohaupt MG, Hediger MA, Frey FJ. Gain-of-function haplotype in the epithelial calcium channel TRPV6 is a risk factor for renal calcium stone formation. Hum Mol Genet 17: 1613-1618, 2008.
88. Thorleifsson G, Holm H, Edvardsson V, Walters GB, Styrkarsdottir U, Gudbjartsson DF, Sulem P, Halldorsson BV, de Vegt VF, d'Ancona FC, den HM, Franzson L, Christiansen C, Alexandersen P, Rafnar T, Kristjansson K, Sigurdsson G, Kiemeney LA, Bodvarsson M, Indri-dason OS, Palsson R, Kong A, Thorsteinsdottir U, Stefansson K. Sequence variants in the CLDN14 gene associate with kidney stones and bone mineral density. Nat Genet 41: 926-930, 2009.
89. Tiselius HG. An improved method for the routine biochemical evaluation of patients with recurrent calcium oxalate stone disease. Clin Chim Acta 122: 409-418, 1982.
90. Tsuruoka S, Bushinsky DA, Schwartz GJ. Defective renal calcium reabsorption in genetic hypercalciuric rats. Kidney Int 51: 1540-1547, 1997.
91. Vandesompele J, De Preter K, Pattyn F, Poppe B, Van Roy N, De Paepe A, Speleman F. Accurate normalization of real-time quantitative RT-PCR data by geometric averaging of multiple internal control genes. Genome Biol 3: RESEARCH0034, 2002.
92. Wang W, Kwon TH, Li C, Frøkiær J, Knepper MA, Nielsen S. Reduced expression of Na-K-2Cl cotransporter in medullary TAL in vitamin D-induced hypercalcemia in rats. Am J Physiol Renal Physiol 282: F34-F44, 2002.
93. Weber K, Erben RG, Rump A, Adamski J. Gene structure and regulation of the murine epithelial calcium channels ECaC1 and 2. Biochem Biophys Res Commun 289: 1287-1294, 2001.
94. Werness PG, Brown CM, Smith LH, Finlayson B. Equil2: A BASIC computer program for the calculation of urinary saturation. J Urol 134: 1242-1244, 1985.
95. 2+ absorption. Am J Physiol Gastrointest Liver Physiol 303: G879-G885, 2012.
96. Yamauchi D, Raveendran NN, Pondugula SR, Kampalli SB, Sanne-man JD, Harbidge DG, Marcus DC. Vitamin D upregulates expression of ECaC1 mRNA in semicircular canal. Biochem Biophys Res Commun 331: 1353-1357, 2005.
97. Yao J, Karnauskas AJ, Bushinsky DA, Favus MJ. Regulation of renal calcium-sensing receptor gene expression in response to 1,25(OH)2D3 in genetic hypercalciuric stone forming rats. J Am Soc Nephrol 16: 1300-1308, 2005.
98. Yao J, Kathpalia P, Bushinsky DA, Favus MJ. Hyperresponsiveness of vitamin D receptor gene expression to 1,25-dihydroxyvitamin D3: A new characteristic of genetic hypercalciuric stone-forming rats. J Clin Invest 101: 2223-2232, 1998.
99. Zerwekh JE, Reed BY, Heller HJ, Gonzalez GB, Haussler MR, Pak CY. Normal vitamin D receptor concentration and responsiveness to 1,25-dihydroxyvitamin D3 in skin fibroblasts from patients with absorptive hypercalciuria. Miner Electrolyte Metab 24: 307-313, 1998.